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Abstract  
 
Objectives: There is a clinical impression of dissatisfaction with treatment for 
hypothyroidism amongst some patients. Psychometric properties of the new ThyTSQ 
questionnaire are evaluated. The questionnaire, measuring patients’ satisfaction with 
their treatment for hypothyroidism, has two parts: the 7-item ThyTSQ-Present and 4-item 
ThyTSQ-Past, measuring satisfaction with present and past treatment respectively on 
scales from 6 (very satisfied) to 0 (very dissatisfied).  
Methods: The questionnaire was completed once by 103 adults with hypothyroidism, 
age [mean (S.D.) 55.2 (14.4), range 23–84 years], (all treated with thyroxine).  
Results: Completion rates were very high. Internal consistency reliability was excellent 
for both ThyTSQ-Present and ThyTSQ-Past [Cronbach’s alpha = 0.91 and 0.90 
respectively, (N =102 and 103)]. Principal components analyses indicated that the seven 
items of the ThyTSQ-Present and the four items of the ThyTSQ-Past could be summed 
into separate Present Satisfaction and Past Satisfaction total scores. Mean Present 
Satisfaction was 32.5 (7.8), maximum range 0–42, and mean Past Satisfaction was 17.5 
(6.1), maximum range 0–24, indicating considerable room for improvement. Patients 
were least satisfied with their present understanding of their condition, mean 4.2 (1.7) 
[maximum range 0–6], and with information provided about hypothyroidism around the 
time of diagnosis, mean 3.9 (1.8), [maximum range 0–6]. 
Conclusions: The ThyTSQ is highly acceptable to patients with hypothyroidism (excellent 
completion rates), and has established internal consistency reliability. It will assist health 
professionals in considering psychological outcomes when treating people with 
hypothyroidism, and is suitable for clinical trials and routine clinical monitoring.  
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Introduction 
Hypothyroidism is a common chronic endocrine disorder [1, 2]  with physical symptoms 
associated with slowing of the metabolism, such as weight gain or cold intolerance, and 
also psychological symptoms, including reduced cognitive functioning [3]. The standard 
treatment is thyroxine (T4) replacement therapy which is converted to the more 
metabolically active triiodothyronine (T3) in the peripheral tissues [4].  This treatment 
returns patients to a biochemical euthyroid state, with normal levels of Thyroid 
Stimulating Hormone (TSH) concentration and serum Free T4 (FT4). However, some 
patients continue to report persistent symptoms despite their TSH and FT4 levels being 
within the reference ranges indicating that their T4 replacement is adequate [5]. For 
example one study found that the number of individuals with significant impairment in 
psychological well-being was 21% higher in thyroxine-treated patients than euthyroid 
controls of similar age and sex, even though patients’ TSH levels were within the normal 
laboratory reference range [6]. Some patients report increased well-being only with 
slightly elevated FT4 and low or undetectable TSH [7]. There is much controversy about 
the interpretation of TSH levels and appropriate T4 dosage to alleviate persistent 
symptoms but avoiding possible long-term effects of excessive T4 replacement 
(osteoporosis and heart disease) [8], and whether to treat those with subclinical 
hypothyroidism or not [9, 10] or add T3 to the standard T4 therapy [11].  
 
Patients may express their dissatisfaction with treatment in patients’ newsletters (e.g. 
British Thyroid Foundation) and there are anecdotal reports from clinicians of continuing 
dissatisfaction in some of their patients [12]. Poor adherence to treatment by patients is 
not uncommon [13], perhaps reflecting dissatisfaction with the treatment. Walsh defined 
dissatisfaction with thyroxine therapy as “persistence or recurrence of symptoms of 
hypothyroidism despite apparently adequate thyroxine replacement” and remarked that 
its prevalence among thyroxine-treated patients was not known and that further research 
in this “neglected area” should be encouraged [12]. A questionnaire measuring patients’ 
satisfaction with treatment for hypothyroidism has been designed recently: the 
Underactive Thyroid Treatment Satisfaction Questionnaire (ThyTSQ) [14], the first 
known measure of its kind for patients with hypothyroidism. During the qualitative design 
stage of the ThyTSQ design work, (fully reported elsewhere [14]), semi-structured 
interviews were conducted with 38 patients in which patients talked about their 
experiences of treatment and completed and commented on the draft questionnaire.  
Possible changes were discussed and new or modified items piloted with subsequent 
patients. Weak draft items were eliminated at this stage and checks made that 
instructions and questions were understood and responded to easily. Although the aim 
was to design a measure of patients’ satisfaction with their current treatment for 
hypothyroidism, half the patients in the early interviews (10/20) spontaneously reported 
negative experiences of treatment around the time of diagnosis. These negative 
experiences related to delays in diagnosis, and/ or in prescribing thyroxine treatment, 
and/ or lack of information provided about the condition or the treatment. Even though 
patients’ experience of current treatment might be positive, in some cases these past 
negative experiences interfered with completion of questions about current treatment, 
because patients wanted to express their dissatisfaction with earlier treatment/ perceived 
mistreatment. A separate section was therefore drawn up, after half the interviews had 
been conducted, with questions covering satisfaction with past treatment around the 
time of diagnosis, the ThyTSQ-Past. It is an extension of the main questionnaire, the 
ThyTSQ-Present, which measures satisfaction with current treatment. The design of the 
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ThyTSQ is based on the widely used Diabetes Treatment Satisfaction Questionnaire 
(DTSQ) [15-17] and related questionnaires for people with renal disease (RTSQ) [18], 
Human Immunodeficiency Virus (HIVTSQ) [19], and diabetic retinopathy (RetTSQ) [20], 
but hypothyroidism is the first disorder for which it has been found necessary, at the 
design stage, to produce a separate section on past satisfaction with early treatment 
around the time of diagnosis.   
 
The psychometric properties of the ThyTSQ (factor structure, and aspects of reliability 
and validity) need to be evaluated so that the new measure may be used to identify 
patients dissatisfied with their current treatment regimen and in clinical trials of any new 
treatments or treatment combinations in the future.  This was undertaken in a cross-
sectional survey of patients in Gateshead, UK. The Gateshead Local Research Ethics 
Committee gave approval for the study and patients provided their informed consent. 
 
Methods 
The ThyTSQ  
The ThyTSQ-Present has seven items including questions about satisfaction with current 
treatment, and control of symptoms of underactive thyroid, (Table 1).  Instructions ask 
patients to consider their experience of treatment for underactive thyroid over the 
previous few weeks.  Patients respond to each item by circling a number on a scale from 
6 to 0, (where 3 is considered a neutral option), indicating their degree of satisfaction 
with that aspect of treatment e.g. from very satisfied to very dissatisfied, as in the 
following example (item 1 of the ThyTSQ-Present): 
 
How satisfied are you with the current treatment for your underactive thyroid? 
very satisfied        6      5         4   3        2        1        0         very dissatisfied 
 
The ThyTSQ-Past has four items concerning satisfaction with the way doctors dealt with 
the patient or the thyroid condition around the time of diagnosis, and satisfaction with 
information provided about the condition and its treatment (Table 1). Instructions inform 
respondents that the items are concerned with their early experiences both before and 
after they were told they had underactive thyroid. At the end of each part there is a ‘free 
comments’ section in which respondents are asked if there are any other features of 
their treatment [i.e. recent treatment (ThyTSQ-Present), or early treatment (ThyTSQ-
Past)] causing either satisfaction or dissatisfaction, that have not been covered by the 
questionnaire. These open sections allow for the addition of further domains to the 
questionnaire in the future, if necessary, for its continuing development. 
 
Recruitment 
Study participants were recruited from the Diabetes and Endocrinology Clinic at the 
Queen Elizabeth Hospital Gateshead, UK and three local Primary Care Practices. 
Inclusion criteria: age 18+ years (no upper limit); a diagnosis of hypothyroidism on the 
basis of two blood tests taken at least three months apart i.e. no patient had transient 
hypothyroidism.  People with mental health problems that would render them incapable 
of understanding and completing the questionnaire were excluded from the study.   
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Statistical analyses 
Normality of distributions was determined through investigation of histograms and z 
(skew) scores, where z (skew) scores within ± 2.58 are indicative of normality [21]. 
Cronbach’s alpha coefficient of internal consistency reliability was determined [22].  An 
alpha of 0.8 was taken as the minimum acceptable [23], but 0.9 was preferable as it is 
considered by some to be the minimum for making decisions about individuals [24]. 
Acceptable item-total correlations were those ≥ 0.2 [25]. Factor structure was explored 
using principal components analysis. Salient loadings were taken as ≥ 0.4.  This is 
higher than the recommended minimum 0.3 [26], erring on the side of caution in an effort 
to reduce the risk of spurious loadings that owed their origin to any non-normality of item 
distributions, and also to avoid double loadings.  A minimum of five respondents per 
questionnaire item is required for factor analysis [27], and the obtained sample size 
(103) was more than sufficient to factor analyse the two parts of the ThyTSQ (containing 
seven and four items separately or eleven combined together) [26].   
 
Exploratory correlations were undertaken between ThyTSQ variables and age, and with 
biomedical variables: Body Mass Index (BMI), duration of hypothyroidism, and the most 
recent available TSH measurement obtained from biochemical thyroid function tests. 
Insufficient data were obtained on FT4 measurements (see Results section below) and 
these were not included in correlational analysis. Correlations were investigated using 
Pearson’s r for normally distributed, and Spearman’s rho for skewed data. Sub-group 
analyses explored differences in sex, and cause of hypothyroidism (autoimmune vs. 
iatrogenic), using t-test or Mann-Whitney test for normally distributed and skewed data 
respectively, and differences in TSH level (within the reference range, above or below 
this range) using Univariate Analysis of Variance (ANOVA). As this was an exploratory 
study, the Bonferroni correction for ‘familywise’ error in multiple tests was not performed. 
Means are reported as mean (standard deviation). Two-tailed significance applied. 
Analyses were conducted using SPSS for Windows Version 9. 
 
Results 
Recruitment 
Of the 130 patients invited to complete the ThyTSQ, 103 accepted and returned 
completed questionnaires, (an acceptance rate of 79%): Queen Elizabeth Hospital (40 
patients), and three local primary care practices, (A, B, and C), (providing 9, 6, and 48 
patients respectively). There were four methods of recruitment: face-to-face (20%), letter 
(48%), telephone (1%) and combined letter plus telephone (31%).  
 
Questionnaire completion rates  
Completion rates for the ThyTSQ were > 99.8% whether at the hospital, where 
healthcare professionals prompted respondents to complete any missed items on the 
questionnaires, or at the three primary care clinics (where patients were not prompted to 
complete missing data). The Flesch Reading Ease statistic [28] was calculated to be 
54.1 (ThyTSQ-Present) and 57.2 (ThyTSQ-Past). These are slightly less than the 
optimal 60-70 (in a possible score range of 0 to 100, where a higher score indicates 
 6
greater reading ease). The Flesch statistic takes into account the average number of 
syllables per word and words such as “underactive” and “dissatisfied”, having four 
syllables, detract from the score though are not found to be difficult words. The high 
completion rates, however, indicated that the questionnaire was readily understood by 
this sample of respondents. 
 
The study sample characteristics 
The average age of the sample was 55.2 (standard deviation 14.4) years, with a mean 
duration of hypothyroidism of 8.7 (9.1) years. The great majority of patients had 
autoimmune hypothyroidism (88%) of whom four patients had subclinical 
hypothyroidism.  All patients were receiving thyroxine replacement. The ratio of women 
to men was 85 : 18, similar to the sex ratio of thyroid disease found in the general US 
population in a recent study [2]. Recent measurements of TSH levels were available for 
88 patients but, in the case of FT4 levels, only 43 patients (42%) as FT4 levels are only 
measured if the TSH levels are outside the reference range.  See Table 2 for full details 
of the sample characteristics. Details are available for 18 of the 27 people who did not 
respond to the invitation to complete the questionnaire. They were all white women, with 
a mean age of 53.4 (11.5) years (not significantly different from the age of the 
participants, p = 0.63).  
 
Analyses, using methods adopted elsewhere [29], showed that there were no systematic 
differences in the data from the four recruitment sources, and that these data could be 
treated as one for the purposes of reliability and factor analysis, where larger N is 
desirable, (full results not reported).  
 
Reliability and factor analyses 
The 7-item ThyTSQ-Present had very high internal consistency reliability [Cronbach's 
alpha = 0.907, standardised item alpha = 0.914, (N = 102)]. All corrected item-total 
correlations were satisfactory, the lowest being 0.504 (item 4:understanding of 
condition), which was also the only item to increase overall scale alpha if deleted (alpha 
if item deleted was 0.925) and therefore detract slightly from the scale reliability while 
broadening the content. The 4-item ThyTSQ-Past had high internal consistency reliability 
[Cronbach's alpha = 0.896, standardised item alpha = 0.896, (N = 103)]. All corrected 
item-total correlations were satisfactory, the lowest being 0.692 (item 1:past satisfaction). 
No item detracted from the ThyTSQ-Past scale alpha.  
 
An unforced principal components analysis, conducted on the 11 items, (transformed to 
near normality), of the two questionnaires combined, produced two clean factors: 
Component 1 had all ThyTSQ-Present items loading > 0.65; Component 2 had all four 
ThyTSQ-Past items loading > 0.82 (Table 3). Separate unforced principal components 
analyses of both ThyTSQ-Present and ThyTSQ-Past variables produced single 
components with an eigenvalue > 1, accounting for 63.8% (ThyTSQ-Present) and 77.2% 
(ThyTSQ-Past) of the variance (Table 3).  This indicated that all seven ThyTSQ-Present 
items could be summed into a ThyTSQ-Present Satisfaction score (range 0 to 42) and all 
four ThyTSQ-Past items could be summed into a separate ThyTSQ-Past Satisfaction 
score (range 0 to 24). A lower score indicates greater dissatisfaction with treatment, and 
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a higher score indicates greater satisfaction with treatment.  We do not recommend 
summing the Present and Past Satisfaction scores into an overall Treatment Satisfaction 
score for the two sections combined. The correlation between the Past and Present 
Satisfaction scores was rho = 0.649, p< 0.001, N = 102, an indication that the two scales 
are not measuring the same construct, as a correlation < 0.7 falls short of the convention 
indicating adequate convergence of scales [30].  Further reliability analyses were 
conducted using a method reported previously [31] that showed calculation of overall 
ThyTSQ-Present Satisfaction score was reliable at alpha = 0.9 with no items of missing 
data and reliable at alpha = 0.8 with up to two items of missing data, and ThyTSQ-Past 
Satisfaction score was reliable at alpha = 0.8 with no more than one item of missing 
data.  
 
Descriptive statistics 
Non-normality, (negative skew towards high satisfaction with treatment) was found in 
most ThyTSQ items and was dealt with successfully by conducting reflect and log 
transformations, leaving two items with a small degree of non-normality [z (skew) = 4.2]. 
ThyTSQ-Present item means (Fig. 1, Table 1) indicate that overall patients were 
satisfied with all aspects of their treatment. Patients were most satisfied with 
convenience of treatment (item 3, mean 5.24), and least satisfied with their 
understanding of their condition (item 4, mean 4.19). Mean Present Satisfaction was 
32.5 (7.8) (maximum possible range 0 – 42). Of the six patients (5.9%) who had Present 
Satisfaction scores of < 21 (expressing dissatisfaction with current  treatment) five had 
available TSH measurements: mean 1.64, range 0.12 to 3.53, i.e. were being treated so 
that their TSH levels were within the laboratory reference range of 0.4 to 4.0 mu/L. 
Patients were more satisfied than dissatisfied with all four aspects measured by the 
ThyTSQ-Past (Fig. 1, Table 1), but had least satisfaction with information provided about 
the condition or its treatment at time of diagnosis. Mean Past Satisfaction was 17.5 (6.1) 
(maximum possible range 0 – 24). Nineteen patients (18.4%) had Past Satisfaction 
scores < 12 indicating overall dissatisfaction with past treatment.  
 
Correlations  
ThyTSQ-Present 7:continue correlated negatively with BMI (rho = -0.23, p = 0.03, N = 
92),  3:convenient correlated with TSH levels (rho = -0.22, p = 0.04, N = 88) indicating 
that those with high BMI were more dissatisfied to continue their present treatment, and 
those with high TSH levels were more dissatisfied with convenience of treatment. 
Variables 1:present satisfaction, 2:how well working, 6:controlling symptoms and 
7:continue all correlated positively with age (rho values ranged from 0.32 to 0.40, p ≤ 
0.001, N ranging 102 to 103). ThyTSQ-Past 1:past satisfaction and 2:information-
condition also correlated with age (rho = 0.23 and 0.21 respectively, p < 0.05) indicating 
improved satisfaction with increasing age. There were no significant correlations 
between the Satisfaction scores and the number of comorbid conditions that patients 
had or duration of hypothyroidism.  
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Sub-group differences in ThyTSQ variables   
The only significant sub-group difference found was a sex difference: women had higher 
satisfaction with the control of their hypothyroid symptoms, median 5, compared with 
men, median 4 (U = 528.5, p = 0.034) There were no significant differences in ThyTSQ-
Present or Past Satisfaction scores, between respondents whose TSH levels were within 
the reference range of 0.4 to 4.0 mU/L, (N = 46), and those below (N = 12), and above 
this range (N = 29) (p = 0.092), nor between those who had autoimmune hypothyroidism 
(N = 91) and those with hypothyroidism caused by treatment (N = 12).   
 
Free comments sections 
The free comments sections were used by 12 patients (ThyTSQ-Present) and 19 
patients (ThyTSQ-Past), all of whom expressed dissatisfaction with treatment. 
Comments were carefully considered, but analysis showed that these areas of 
dissatisfaction were either already covered in the questionnaires or insufficient numbers 
of patients (≤ 2) mentioned them to justify the addition of new items. Comments (one 
respondent in each case) on the ThyTSQ-Present included: problems with forgetting to 
take daily medication (covered by item 3:convenient, which specifically mentions 
remembering to take the medication), concerns about treatment dose (lack of stable 
dose, incorrect dose), desire for alternative therapies, including more holistic approaches 
(all could be covered by 1:present satisfaction and/ or 7:continue). Nine patients (8.7%) 
reported dissatisfaction about aspects of the way doctors had dealt with their 
underactive thyroid around the time it was first diagnosed, including the time taken to 
diagnose their thyroid problem or prescribe treatment (six patients), especially if they 
were ‘borderline’ between overt and subclinical hypothyroidism (covered by 1:past 
satisfaction). Other comments (one respondent in each case) on the ThyTSQ-Past 
included: aspects of patients’ understanding of their condition or its treatment, for 
example the length of time to reach a satisfactory dosage (covered by 2:information-
condition and 3:information-treatment); or being told that their symptoms were ‘in the 
mind’ (covered by 4:taken seriously).  
 
 
Discussion 
We report the psychometric evaluation of the recently designed ThyTSQ measure of 
patient satisfaction with treatment for hypothyroidism. The ThyTSQ-Present measures 
satisfaction with present treatment, and the ThyTSQ-Past measures satisfaction with 
treatment around the time of diagnosis, but treatment in the broader sense of the term, 
to include medical care and interactions with healthcare professionals. Use of the 
ThyTSQ-Past is recommended to avoid any negative experiences of past treatment 
interfering with completion of questions about current treatment, though if it were used in 
a clinical trial it might only be completed once, at baseline, (in the present study they 
were used together).  Use of the ThyTSQ-Present alone without the ThyTSQ-Past would 
need further psychometric evaluation. The measure is short and quick to complete, with 
minimal respondent burden, and the very high completion rates indicated good 
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acceptability to respondents. The factor structure was clear. When the 11 items of both 
sections were combined in one unforced factor analysis, two clean factors emerged, with 
Past and Present items loading on separate factors. Unforced analyses performed on 
each separate section produced one factor each, with very high factor loadings, which 
lent support for summing the individual item scores into Present and Past Satisfaction 
scores. The internal consistency reliability of each section was also excellent. The 
moderate correlation between the total scores of the two parts is an indication that they 
are measuring different but related constructs.  
 
When the free comments were analysed, they showed that the areas of dissatisfaction 
mentioned were, for the most part, already covered by the items of the questionnaire, 
suggesting that respondents were emphasising or explaining dissatisfaction already 
reflected in existing items.  Insufficient numbers of patients specified particular issues to 
justify the addition of new items, hence the measure would appear to have good content 
validity, however, the measure is still at a relatively early stage of development, and new 
items may be added in the future when more data become available. Construct validity 
was not assessed in this exploratory study as no prior hypotheses were formulated. The 
only significant sub-group difference found was that women had higher satisfaction than 
men with the control of their hypothyroid symptoms. Satisfaction improved with 
increasing age for both Past and Present scores, perhaps because people expect to 
have more health problems as they grow older and, with lower expectations of treatment, 
are more likely to be satisfied with treatment.  
 
Generally high satisfaction rates were found, but a small proportion of patients were 
dissatisfied, giving support to anecdotal reports from clinicians. More patients expressed 
dissatisfaction with their present understanding of the condition and with information 
provided about the condition in the past than any other item on the ThyTSQ-Present and 
Past respectively. Although dissatisfaction with thyroxine therapy has been defined in 
relation to persistence of symptoms [12], it is clear, not only from interviews conducted 
when developing this questionnaire [14] but also from the analyses presented here, that 
symptoms are not the only aspect causing dissatisfaction.  This study has found support 
for having the section on satisfaction with past treatment, and some patients clearly 
welcomed the opportunity to report their dissatisfaction as evidenced by the larger 
number of patients using the free comments section of the ThyTSQ-Past. 
 
This study has shown that more consideration needs to be given to the interaction 
between patient and doctor at the time of diagnosis. More consultation time may be 
required at the point when a patient is first told that they have a condition that requires 
life-long treatment. Patients may be too distressed, at the time they are first told they 
have hypothyroidism, to absorb much of the information they are given, especially as 
cognitive functioning of people with untreated hypothyroidism is reduced in some cases 
[32]. They may welcome information leaflets that they can take home and study in their 
own time. Whilst the daily tablet regimen in itself is not complicated, some patients may 
not understand why their dosage must be increased slowly until equilibrium is reached 
between hypo and hyperthyroidism.  Others may be despondent if treatment does not 
return them to their previous state before onset, and not fully adhere to the tablet 
treatment regimen.  Thus it is possible that increased adherence to treatment would 
result if patients understood their treatment better. Use of the ThyTSQ questionnaire will 
pinpoint lack of understanding in individual patients, who can then receive more help 
from healthcare professionals.  
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Although further studies will be needed in the future to assess test-retest reliability, 
sensitivity to change (ThyTSQ-Present only), and construct validity, the questionnaire is 
now ready to be used in clinical trials of treatments for hypothyroidism. It can be used 
also with individual patients, completed questionnaires forming the basis for discussion 
between patients and healthcare professionals. 
 
 
Conclusions 
The ThyTSQ is a new self-completion measure of satisfaction with treatment in 
hypothyroidism with sections measuring present satisfaction with treatment, and past 
satisfaction with treatment around the time of diagnosis.  The questionnaire is performing 
well: it has good acceptability to respondents, and excellent internal consistency 
reliability.  A Satisfaction score is calculated for each section, ThyTSQ-Present and 
ThyTSQ-Past, or individual items can be analysed separately if required. The ThyTSQ 
appears to be a valuable tool for use in clinical trials or to use in routine care of individual 
patients. Its test-retest reliability and sensitivity to change now need to be evaluated in 
clinical trials.  
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Table 1: ThyTSQ items and their response options, with item means 
No Abbreviation ThyTSQ-Present item wording Response options Mean (S.D.)  Median N 
1 
 
present 
satisfaction 
How satisfied are you with the current treatment for your 
underactive thyroid? 
very satisfied – very 
dissatisfied 
4.89 (1.27) 5 103 
2 how well 
working 
How well do you feel the treatment is working? 
 
very well – very badly 4.22 (1.47) 4 102 
3 convenient 
 
How convenient have you found your treatment to be 
recently (e.g. remembering to take the medication, getting 
prescriptions)? 
very convenient – very 
inconvenient 
5.24 (1.18) 6 103 
4 understanding 
of condition 
How satisfied are you with your understanding of your 
underactive thyroid? 
very satisfied – very 
dissatisfied 
4.19 (1.73) 5 103 
5 encourage 
 
Would you encourage someone else with underactive thyroid 
to have your kind of treatment? 
Yes, I would definitely 
encourage them – No, 
I would definitely not 
encourage them 
5.10 (1.26) 6 103 
6 controlling 
symptoms 
How well do you feel that the treatment is controlling 
symptoms of underactive thyroid? 
very well – very badly 4.36 (1.27) 4 103 
7 continue 
 
How satisfied would you be to continue with your present 
treatment and dose? 
very satisfied – very 
dissatisfied 
4.52 (1.43) 5 103 
  ThyTSQ-Past item wording     
  How satisfied were you……     
1 
 
past 
satisfaction 
…with the way doctors dealt with your underactive thyroid 
around the time it was first diagnosed? 
very satisfied – very 
dissatisfied 
4.72 (1.68) 5 103
2 information -
condition 
…with the information provided by doctors about underactive 
thyroid?  
very satisfied – very 
dissatisfied 
   3.94 (1.80) 4 103
3 information -
treatment  
…with the information provided by doctors about the 
treatment for underactive thyroid? 
very satisfied – very 
dissatisfied 
4.20 (1.72) 4 103
4 taken 
seriously 
…that doctors took you and your underactive thyroid 
seriously? 
very satisfied – very 
dissatisfied 
4.59 (1.78) 5 103
S.D.: standard deviation 
ThyTSQ-Present © Prof Clare Bradley: 22.7.03.  
ThyTSQ-Past © Prof Clare Bradley: 22.7.03.  
For access to questionnaire see paragraph on copyright. 
 
Table 2: Characteristics of ThyTSQ respondents (N = 103)  
 Mean (S.D.) [range] N
Mean age (years) 55.2 (14.4) [23 – 84]          103
Mean duration of hypothyroidism (years)   8.7 (9.1)   [0.25 – 57]       96
Age at leaving full-time education (years) 16.2 (2.5)   [14 – 27]          87
BMI (kg/m2) 28.6 (6.2)   [18 – 48.8]       92
TSH (mu/L)   3.8 (5.2)   [0.02 – 28.7]    88
FT4 (pmol/L) 18.0 (4.4)   [8.9 – 28.4]      43
  
Ratio women to men   85 : 18
Ratio White to non-white  102 : 1
Hypothyroidism:   
     Autoimmune  87 
     Secondary to treatment for thyroid cancer or            
hyperthyroidism 
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     Secondary to lithium treatment   1
     Secondary to amiodarone treatment   2
     Subclinical (autoimmune)*  4 
 
Comorbid conditions occurring in two or more patients: ischaemic heart disease (9), osteoarthritis (9), 
Type 2 diabetes (8), asthma (7), Type 1 diabetes (6), rheumatic disorder (6), cancer (4), pregnancy (4), 
Addison’s disease (3), depression (3), pernicious anaemia (3), coeliac disease (2). 
*Subclinical hypothyroidism defined as: TSH level > 4mu/L and FT4 level in normal range (9 to 25 pmol/L) 
[33] 
S.D.: standard deviation; BMI: body mass index; TSH: thyroid stimulating hormone; FT4: free thyroxine 
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Table 3: Unforced factor loadings of the ThyTSQ-Present and ThyTSQ-Past  
 Separate analyses* Combined analyses** 
ThyTSQ-Present   Component Component 1 Component 2 
1:present satisfaction .822 .823 .019 
2:how well working .871 .866 -.093 
3:convenient .653 .656 .049 
4:understanding of condition .661 .655 -.131 
5:encourage .813 .815 -.014 
6:controlling symptoms .874 .868 -.139 
7:continue .863 .867 .043 
  
ThyTSQ-Past  
1:past satisfaction .822 -.028 .824 
2:information-condition .914 -.107 .908 
3:information-treatment .914 -.055 .908 
4:taken seriously .861 .032 .858 
Principal components analyses with Varimax rotation conducted on each section (Past and Present) 
separately* and on the 11 items of the Past and Present sections combined**.  
Satisfactory loadings (≥ 0.4). 
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